GENEVA, Sept. 24 -- REJDAK, Konrad filed a patent application (EP2026/057819) for “CLADRIBINE FOR TREATING IMMUNE-MEDIATED CENTRAL NERVOUS SYSTEM DISEASE (IMCNSD)”. With publication no. WO/2026/195813, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/7076
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....